Early visual alterations in individuals at-risk of Alzheimer’s disease: a multidisciplinary approach

Abstract

Background The earliest pathological features of Alzheimer’s disease (AD) appear decades before the clinical symptoms. The pathology affects the brain and the eye, leading to retinal structural changes and functional visual alterations. Healthy individuals at high risk of developing AD present alterations in these ophthalmological measures, as well as in resting-state electrophysiological activity. However, it is unknown whether the ophthalmological alterations are related to the visual-related electrophysiological activity. Elucidating this relationship is paramount to understand the mechanisms underlying the early deterioration of the system and an important step in assessing the suitability of these measures as early biomarkers of disease. Methods In total, 144 healthy subjects: 105 with family history of AD and 39 without, underwent ophthalmologic analysis, magnetoencephalography recording, and genotyping. A subdivision was made to compare groups with less demographic and more risk differences: 28 high-risk subjects (relatives/APOEɛ4 +) and 16 low-risk (non-relatives/APOEɛ4 −). Differences in visual acuity, contrast sensitivity, and macular thickness were evaluated. Correlations between each variable and visual-related electrophysiological measures (M100 latency and time–frequency power) were calculated for each group. Results High-risk groups showed increased visual acuity. Visual acuity was also related to a lower M100 latency and a greater power time–frequency cluster in the high-risk group. Low-risk groups did not show this relationship. High-risk groups presented trends towards a greater contrast sensitivity that did not remain significant after correction for multiple comparisons. The highest-risk group showed trends towards the thinning of the inner plexiform and inner nuclear layers that did not remain significant after correction. The correlation between contrast sensitivity and macular thickness, and the electrophysiological measures were not significant after correction. The difference between the high- and low- risk groups correlations was no significant. Conclusions To our knowledge, this paper is the first of its kind, assessing the relationship between ophthalmological and electrophysiological measures in healthy subjects at distinct levels of risk of AD. The results are novel and unexpected, showing an increase in visual acuity among high-risk subjects, who also exhibit a relationship between this measure and visual-related electrophysiological activity. These results have not been previously explored and could constitute a useful object of research as biomarkers for early detection and the evaluation of potential interventions’ effectiveness.

Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease

“…Surprisingly, AD patients, with a high genetic risk of developing Alzheimer's disease (i.e., carrier of at least one ε4 allele for the ApoE gene), have shown an unexpected increase in visual acuity and contrast sensitivity [87].…”

Recent Developments in the Design and Fabrication of Electrochemical Biosensors Using Functional Materials and Molecules

“…Moreover, identifying these diseases in their early stages might give us a chance to eliminate these diseases, or could suppress the disease growth rate. Therefore, it is indispensable to detect and quantify various analytes from biofluids and environmental samples [ 162 , 163 , 164 , 165 ]. Electrochemical sensors and biosensors play a significant role in the detection and quantification of biologically and environmentally important analytes due to their high selectivity and sensitivity towards target analytes, and even a small change in concentration would show an immediate response.…”

A Survey of Deep Learning for Alzheimer’s Disease

“…The biological process that leads to AD may begin more than 20 years before symptoms appear [11]. The current understanding of AD pathogenesis is based on amyloid peptide deposition and the accumulation and phosphorylation of tau proteins around neurons [12][13][14], which leads to neurodegeneration and eventual brain atrophy.…”